Review



recombinant gr protein  (Cusabio)


Bioz Verified Symbol Cusabio is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Cusabio recombinant gr protein
    Recombinant Gr Protein, supplied by Cusabio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+receptor/Recombinant+Human+Glucocorticoid+receptor(NR3C1)%2Cpartial/pm42850726-117-20-24
    Average 94 stars, based on 1 article reviews
    recombinant gr protein - by Bioz Stars, 2026-10
    94/100 stars

    Images

    Related Articles

    other:

    Article Title: RIPK3 mediates pathogenesis of experimental ventilator-induced lung injury
    Article Snippet: Plasma was subsequently divided into aliquots and kept at –80 o C. RIPK3 was assayed in duplicate using the Human Receptor-interacting serine/threonine-protein kinase 3 (RIPK3) ELISA kit (CSB-EL019737HU, CUSABIO) ( 18 ).

    Article Title: Calprotectin and Receptor for Advanced Glycation End Products as a Potential Biomarker in Abdominal Aortic Aneurysm
    Article Snippet: Receptors binding end products of glycation in plasma were marked with the immunoenzymatic method (ELISA) with the use of the Human Receptor for Advanced Glycation End Products (RAGE/AGER) ELISA Kit (Cusabio, Fannin St. Houston, TX, USA), by a sandwich method with the use of antibodies against receptors binding end products of glycation and horseradish peroxidase (HRP) enzyme.

    Enzyme-linked Immunosorbent Assay:

    Article Title: RIPK1–RIPK3–MLKL-Associated Necroptosis Drives Leishmania infantum Killing in Neutrophils
    Article Snippet: .. For the quantitative determination of human receptor interacting protein kinase 3 (RIPK3) concentrations in cell lysates we used a Human Receptor-Interacting Serine/Threonine-Protein Kinase 3 (RIPK3) ELISA Kit (CUSABIO). ..

    Article Title: Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study
    Article Snippet: ELISA was used for the quantitative determination of AGEs using a commercially available kit (Cusabio Biotech Co. Ltd., Wilmington, DE, USA) according to the manufacturer’s protocol. .. Inter- and intra-assay coefficients of variation were 12.5 and 8.2, respectively, for AGEs. sRAGE in plasmawere marked with the immunoenzymatic method (ELISA) using the Human Receptor for Advanced Glycation End Products (RAGE/AGER) ELISA Kit (Cusabio, Fannin St. Houston, TX, USA) by a sandwich method using anti-RAGE and anti-horseradish peroxidase antibodies. ..

    Intra Assay:

    Article Title: Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study
    Article Snippet: ELISA was used for the quantitative determination of AGEs using a commercially available kit (Cusabio Biotech Co. Ltd., Wilmington, DE, USA) according to the manufacturer’s protocol. .. Inter- and intra-assay coefficients of variation were 12.5 and 8.2, respectively, for AGEs. sRAGE in plasmawere marked with the immunoenzymatic method (ELISA) using the Human Receptor for Advanced Glycation End Products (RAGE/AGER) ELISA Kit (Cusabio, Fannin St. Houston, TX, USA) by a sandwich method using anti-RAGE and anti-horseradish peroxidase antibodies. ..



    Similar Products

    tlr1  (Shanghai Korain Biotech Co Ltd)
    94
    Shanghai Korain Biotech Co Ltd tlr1
    Tlr1, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+receptor/Human+Toll-like+Receptor+10/pm42849185-93-4-16
    Average 94 stars, based on 1 article reviews
    tlr1 - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    human hfrα recombinant protein  (Sino Biological)
    94
    Sino Biological human hfrα recombinant protein
    Human Hfrα Recombinant Protein, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+receptor/Human+FOLR1+%2F+Folate+receptor+alpha+Protein/10__3390_slash_biom16101426-72-4-9
    Average 94 stars, based on 1 article reviews
    human hfrα recombinant protein - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    immunological markers  (Shanghai Korain Biotech Co Ltd)
    92
    Shanghai Korain Biotech Co Ltd immunological markers
    Immunological Markers, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+receptor/Human+Hepatitis+A+Virus+Cellular+Receptor+2/10__31584_slash_jhsmr__20261458-45-35-47
    Average 92 stars, based on 1 article reviews
    immunological markers - by Bioz Stars, 2026-10
    92/100 stars
    		  Buy from Supplier
    il 36receptor antagonist  (Shanghai Korain Biotech Co Ltd)
    94
    Shanghai Korain Biotech Co Ltd il 36receptor antagonist
    Il 36receptor Antagonist, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+receptor/Human+Interleukin-1+Receptor-like+2/pm42873582-27-5-35
    Average 94 stars, based on 1 article reviews
    il 36receptor antagonist - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    mucin like hormone receptor like 2 emr2 cd312 rea302 miltenyi biotec chondroitin sulfate b cd312  (Miltenyi Biotec)
    93
    Miltenyi Biotec mucin like hormone receptor like 2 emr2 cd312 rea302 miltenyi biotec chondroitin sulfate b cd312
    Mucin Like Hormone Receptor Like 2 Emr2 Cd312 Rea302 Miltenyi Biotec Chondroitin Sulfate B Cd312, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+receptor/CD312+(EMR2)+Antibody%2C+anti-human%2C+REAfinity/pm42869215-506-3-11
    Average 93 stars, based on 1 article reviews
    mucin like hormone receptor like 2 emr2 cd312 rea302 miltenyi biotec chondroitin sulfate b cd312 - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    her2  (Elabscience Biotechnology)
    91
    Elabscience Biotechnology her2
    Lactate promotes trastuzumab resistance in gastric cancer by stabilizing HER2 expression. (a) Volcano plot illustrating metabolic differences between gastric cancer tissues from patients who subsequently developed trastuzumab resistance ( n = 6) and those who remained trastuzumab‐sensitive ( n = 6), as determined by untargeted metabolomics analysis. All tissues were surgically resected prior to trastuzumab treatment, and sensitivity or resistance to trastuzumab was subsequently determined based on clinical pathology data and patient follow‐up information. Red dots represent metabolites involved in the glycolytic pathway. (b) Lactate levels in gastric cancer specimens measured using a colorimetric assay kit (all samples assayed in duplicate). Each patient sample is shown in a distinct color, and the two technical replicates from the same patient are shown in the same color. (c) HER2 protein levels measured by <t>enzyme‐linked</t> <t>immunosorbent</t> <t>assay</t> <t>(ELISA)</t> in gastric cancer samples (LAC low , n = 6; LAC High , n = 6). (d,e) HER2 protein levels in AGS cells following treatment with sodium lactate (NALA, 25 or 50 m m ) and lactate (10 or 20 m m ). (f,g) HER2 protein levels in AGS cells following treatment with sodium oxamate (10 or 20 m m ) and stiripentol (100 or 200 µ m ). (h,i) HER2 protein levels in NCI‐N87 cells following treatment with NALA (25 or 50 m m ) and lactate (10 or 20 m m ). (j,k) HER2 protein levels in NCI‐N87 cells following treatment with sodium oxamate (10 or 20 m m ) and stiripentol (100 or 200 µ m ). (l) Flow cytometric analysis of HER2 protein expression in AGS cells treated with NALA or lactate dehydrogenase inhibitors (LDHi) ( n = 3). (m) Flow cytometric analysis of HER2 protein expression in NCI‐N87 cells treated with NALA or LDHi ( n = 3). (n) Representative immunofluorescence (IF) staining and co‐localization analysis of pan‐lactylation and HER2 in gastric cancer tissues (scale bars, 20 µm). (o) Correlation between pan‐lactylation and HER2 expression in gastric cancer tissues (Spearman correlation analysis). (p,q) Lactylation levels of exogenous and endogenous HER2 in cells treated with NALA or LDHi. (r,s) HER2 protein levels in 293T and NCI‐N87 cells treated with LDHi and/or MG132 (10 µ m ). (t,u) Ubiquitination of exogenous and endogenous HER2 following NALA treatment. (v,w) Ubiquitination of exogenous and endogenous HER2 following LDHi treatment. p ‐values were determined by Student's t ‐test; ns, not significant. Data are presented as mean ± SD.
    Her2, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+receptor/Human+EGFR2+(Epidermal+Growth+Factor+Receptor+2)+ELISA+Kit/pmc13655267-248-3-11
    Average 91 stars, based on 1 article reviews
    her2 - by Bioz Stars, 2026-10
    91/100 stars
    		  Buy from Supplier
    recombinant gr protein  (Cusabio)
    94
    Cusabio recombinant gr protein
    Lactate promotes trastuzumab resistance in gastric cancer by stabilizing HER2 expression. (a) Volcano plot illustrating metabolic differences between gastric cancer tissues from patients who subsequently developed trastuzumab resistance ( n = 6) and those who remained trastuzumab‐sensitive ( n = 6), as determined by untargeted metabolomics analysis. All tissues were surgically resected prior to trastuzumab treatment, and sensitivity or resistance to trastuzumab was subsequently determined based on clinical pathology data and patient follow‐up information. Red dots represent metabolites involved in the glycolytic pathway. (b) Lactate levels in gastric cancer specimens measured using a colorimetric assay kit (all samples assayed in duplicate). Each patient sample is shown in a distinct color, and the two technical replicates from the same patient are shown in the same color. (c) HER2 protein levels measured by <t>enzyme‐linked</t> <t>immunosorbent</t> <t>assay</t> <t>(ELISA)</t> in gastric cancer samples (LAC low , n = 6; LAC High , n = 6). (d,e) HER2 protein levels in AGS cells following treatment with sodium lactate (NALA, 25 or 50 m m ) and lactate (10 or 20 m m ). (f,g) HER2 protein levels in AGS cells following treatment with sodium oxamate (10 or 20 m m ) and stiripentol (100 or 200 µ m ). (h,i) HER2 protein levels in NCI‐N87 cells following treatment with NALA (25 or 50 m m ) and lactate (10 or 20 m m ). (j,k) HER2 protein levels in NCI‐N87 cells following treatment with sodium oxamate (10 or 20 m m ) and stiripentol (100 or 200 µ m ). (l) Flow cytometric analysis of HER2 protein expression in AGS cells treated with NALA or lactate dehydrogenase inhibitors (LDHi) ( n = 3). (m) Flow cytometric analysis of HER2 protein expression in NCI‐N87 cells treated with NALA or LDHi ( n = 3). (n) Representative immunofluorescence (IF) staining and co‐localization analysis of pan‐lactylation and HER2 in gastric cancer tissues (scale bars, 20 µm). (o) Correlation between pan‐lactylation and HER2 expression in gastric cancer tissues (Spearman correlation analysis). (p,q) Lactylation levels of exogenous and endogenous HER2 in cells treated with NALA or LDHi. (r,s) HER2 protein levels in 293T and NCI‐N87 cells treated with LDHi and/or MG132 (10 µ m ). (t,u) Ubiquitination of exogenous and endogenous HER2 following NALA treatment. (v,w) Ubiquitination of exogenous and endogenous HER2 following LDHi treatment. p ‐values were determined by Student's t ‐test; ns, not significant. Data are presented as mean ± SD.
    Recombinant Gr Protein, supplied by Cusabio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+receptor/Recombinant+Human+Glucocorticoid+receptor(NR3C1)%2Cpartial/pm42850726-117-20-24
    Average 94 stars, based on 1 article reviews
    recombinant gr protein - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    phagocytic receptor cd91  (Miltenyi Biotec)
    92
    Miltenyi Biotec phagocytic receptor cd91
    Lactate promotes trastuzumab resistance in gastric cancer by stabilizing HER2 expression. (a) Volcano plot illustrating metabolic differences between gastric cancer tissues from patients who subsequently developed trastuzumab resistance ( n = 6) and those who remained trastuzumab‐sensitive ( n = 6), as determined by untargeted metabolomics analysis. All tissues were surgically resected prior to trastuzumab treatment, and sensitivity or resistance to trastuzumab was subsequently determined based on clinical pathology data and patient follow‐up information. Red dots represent metabolites involved in the glycolytic pathway. (b) Lactate levels in gastric cancer specimens measured using a colorimetric assay kit (all samples assayed in duplicate). Each patient sample is shown in a distinct color, and the two technical replicates from the same patient are shown in the same color. (c) HER2 protein levels measured by <t>enzyme‐linked</t> <t>immunosorbent</t> <t>assay</t> <t>(ELISA)</t> in gastric cancer samples (LAC low , n = 6; LAC High , n = 6). (d,e) HER2 protein levels in AGS cells following treatment with sodium lactate (NALA, 25 or 50 m m ) and lactate (10 or 20 m m ). (f,g) HER2 protein levels in AGS cells following treatment with sodium oxamate (10 or 20 m m ) and stiripentol (100 or 200 µ m ). (h,i) HER2 protein levels in NCI‐N87 cells following treatment with NALA (25 or 50 m m ) and lactate (10 or 20 m m ). (j,k) HER2 protein levels in NCI‐N87 cells following treatment with sodium oxamate (10 or 20 m m ) and stiripentol (100 or 200 µ m ). (l) Flow cytometric analysis of HER2 protein expression in AGS cells treated with NALA or lactate dehydrogenase inhibitors (LDHi) ( n = 3). (m) Flow cytometric analysis of HER2 protein expression in NCI‐N87 cells treated with NALA or LDHi ( n = 3). (n) Representative immunofluorescence (IF) staining and co‐localization analysis of pan‐lactylation and HER2 in gastric cancer tissues (scale bars, 20 µm). (o) Correlation between pan‐lactylation and HER2 expression in gastric cancer tissues (Spearman correlation analysis). (p,q) Lactylation levels of exogenous and endogenous HER2 in cells treated with NALA or LDHi. (r,s) HER2 protein levels in 293T and NCI‐N87 cells treated with LDHi and/or MG132 (10 µ m ). (t,u) Ubiquitination of exogenous and endogenous HER2 following NALA treatment. (v,w) Ubiquitination of exogenous and endogenous HER2 following LDHi treatment. p ‐values were determined by Student's t ‐test; ns, not significant. Data are presented as mean ± SD.
    Phagocytic Receptor Cd91, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+receptor/CD91+Antibody%2C+anti-human%2C+REAfinity/pm42834086-289-2-7
    Average 92 stars, based on 1 article reviews
    phagocytic receptor cd91 - by Bioz Stars, 2026-10
    92/100 stars
    		  Buy from Supplier
    ifng elisa kits  (Cusabio)
    94
    Cusabio ifng elisa kits
    Ranked genes by topological metrics of red module.
    Ifng Elisa Kits, supplied by Cusabio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+receptor/Human+Cytokine+receptor+common+subunit+gamma(IL2RG)+ELISA+kit/pmc13677927-142-20-23
    Average 94 stars, based on 1 article reviews
    ifng elisa kits - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    receptor  (MedChemExpress)
    94
    MedChemExpress receptor
    Ranked genes by topological metrics of red module.
    Receptor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+receptor/Fc+epsilon+RIA%2FFCER1A%2C+Human/pm42825366-91-5-15
    Average 94 stars, based on 1 article reviews
    receptor - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Lactate promotes trastuzumab resistance in gastric cancer by stabilizing HER2 expression. (a) Volcano plot illustrating metabolic differences between gastric cancer tissues from patients who subsequently developed trastuzumab resistance ( n = 6) and those who remained trastuzumab‐sensitive ( n = 6), as determined by untargeted metabolomics analysis. All tissues were surgically resected prior to trastuzumab treatment, and sensitivity or resistance to trastuzumab was subsequently determined based on clinical pathology data and patient follow‐up information. Red dots represent metabolites involved in the glycolytic pathway. (b) Lactate levels in gastric cancer specimens measured using a colorimetric assay kit (all samples assayed in duplicate). Each patient sample is shown in a distinct color, and the two technical replicates from the same patient are shown in the same color. (c) HER2 protein levels measured by enzyme‐linked immunosorbent assay (ELISA) in gastric cancer samples (LAC low , n = 6; LAC High , n = 6). (d,e) HER2 protein levels in AGS cells following treatment with sodium lactate (NALA, 25 or 50 m m ) and lactate (10 or 20 m m ). (f,g) HER2 protein levels in AGS cells following treatment with sodium oxamate (10 or 20 m m ) and stiripentol (100 or 200 µ m ). (h,i) HER2 protein levels in NCI‐N87 cells following treatment with NALA (25 or 50 m m ) and lactate (10 or 20 m m ). (j,k) HER2 protein levels in NCI‐N87 cells following treatment with sodium oxamate (10 or 20 m m ) and stiripentol (100 or 200 µ m ). (l) Flow cytometric analysis of HER2 protein expression in AGS cells treated with NALA or lactate dehydrogenase inhibitors (LDHi) ( n = 3). (m) Flow cytometric analysis of HER2 protein expression in NCI‐N87 cells treated with NALA or LDHi ( n = 3). (n) Representative immunofluorescence (IF) staining and co‐localization analysis of pan‐lactylation and HER2 in gastric cancer tissues (scale bars, 20 µm). (o) Correlation between pan‐lactylation and HER2 expression in gastric cancer tissues (Spearman correlation analysis). (p,q) Lactylation levels of exogenous and endogenous HER2 in cells treated with NALA or LDHi. (r,s) HER2 protein levels in 293T and NCI‐N87 cells treated with LDHi and/or MG132 (10 µ m ). (t,u) Ubiquitination of exogenous and endogenous HER2 following NALA treatment. (v,w) Ubiquitination of exogenous and endogenous HER2 following LDHi treatment. p ‐values were determined by Student's t ‐test; ns, not significant. Data are presented as mean ± SD.

    Journal: Advanced Science

    Article Title: Lactylation‐Mediated HER2 Stabilization Promotes Trastuzumab Resistance in Gastric Cancer

    doi: 10.1002/advs.77955

    Figure Lengend Snippet: Lactate promotes trastuzumab resistance in gastric cancer by stabilizing HER2 expression. (a) Volcano plot illustrating metabolic differences between gastric cancer tissues from patients who subsequently developed trastuzumab resistance ( n = 6) and those who remained trastuzumab‐sensitive ( n = 6), as determined by untargeted metabolomics analysis. All tissues were surgically resected prior to trastuzumab treatment, and sensitivity or resistance to trastuzumab was subsequently determined based on clinical pathology data and patient follow‐up information. Red dots represent metabolites involved in the glycolytic pathway. (b) Lactate levels in gastric cancer specimens measured using a colorimetric assay kit (all samples assayed in duplicate). Each patient sample is shown in a distinct color, and the two technical replicates from the same patient are shown in the same color. (c) HER2 protein levels measured by enzyme‐linked immunosorbent assay (ELISA) in gastric cancer samples (LAC low , n = 6; LAC High , n = 6). (d,e) HER2 protein levels in AGS cells following treatment with sodium lactate (NALA, 25 or 50 m m ) and lactate (10 or 20 m m ). (f,g) HER2 protein levels in AGS cells following treatment with sodium oxamate (10 or 20 m m ) and stiripentol (100 or 200 µ m ). (h,i) HER2 protein levels in NCI‐N87 cells following treatment with NALA (25 or 50 m m ) and lactate (10 or 20 m m ). (j,k) HER2 protein levels in NCI‐N87 cells following treatment with sodium oxamate (10 or 20 m m ) and stiripentol (100 or 200 µ m ). (l) Flow cytometric analysis of HER2 protein expression in AGS cells treated with NALA or lactate dehydrogenase inhibitors (LDHi) ( n = 3). (m) Flow cytometric analysis of HER2 protein expression in NCI‐N87 cells treated with NALA or LDHi ( n = 3). (n) Representative immunofluorescence (IF) staining and co‐localization analysis of pan‐lactylation and HER2 in gastric cancer tissues (scale bars, 20 µm). (o) Correlation between pan‐lactylation and HER2 expression in gastric cancer tissues (Spearman correlation analysis). (p,q) Lactylation levels of exogenous and endogenous HER2 in cells treated with NALA or LDHi. (r,s) HER2 protein levels in 293T and NCI‐N87 cells treated with LDHi and/or MG132 (10 µ m ). (t,u) Ubiquitination of exogenous and endogenous HER2 following NALA treatment. (v,w) Ubiquitination of exogenous and endogenous HER2 following LDHi treatment. p ‐values were determined by Student's t ‐test; ns, not significant. Data are presented as mean ± SD.

    Article Snippet: The concentration of HER2 was measured using a commercial ELISA kit (Elabscience E‐EL‐H6083) according to the product's instructions.

    Techniques: Expressing, Analysis, Sensitivity, Pathology, Colorimetric Assay, Enzyme-linked Immunosorbent Assay, Immunofluorescence, Staining, Ubiquitin Proteomics

    Ranked genes by topological metrics of red module.

    Journal: Frontiers in Bioinformatics

    Article Title: Integrating transcriptomic analysis to explore biomarkers and therapeutic targets for rheumatoid arthritis: a case-control and systems biology approach

    doi: 10.3389/fbinf.2026.1891543

    Figure Lengend Snippet: Ranked genes by topological metrics of red module.

    Article Snippet: Further, the concentrations of IL2RG and IFNG in serum samples were quantified following the manufacturer’s protocol of human IL2RG and IFNG ELISA kits (CUSABIO catalog number: CSB-EL011651HU and CSB-E04577h-IS) and measured the absorbance at 450 nm using a Bio-Rad xMark ELISA plate reader.

    Techniques:

    Final six biomarkers identified by SVM-RFE and RF analyses.

    Journal: Frontiers in Bioinformatics

    Article Title: Integrating transcriptomic analysis to explore biomarkers and therapeutic targets for rheumatoid arthritis: a case-control and systems biology approach

    doi: 10.3389/fbinf.2026.1891543

    Figure Lengend Snippet: Final six biomarkers identified by SVM-RFE and RF analyses.

    Article Snippet: Further, the concentrations of IL2RG and IFNG in serum samples were quantified following the manufacturer’s protocol of human IL2RG and IFNG ELISA kits (CUSABIO catalog number: CSB-EL011651HU and CSB-E04577h-IS) and measured the absorbance at 450 nm using a Bio-Rad xMark ELISA plate reader.

    Techniques:

    (a) IL2RG expression level comparison between RA patients and control serum samples; (b) IFNG expression level comparison between RA patients and control serum samples.

    Journal: Frontiers in Bioinformatics

    Article Title: Integrating transcriptomic analysis to explore biomarkers and therapeutic targets for rheumatoid arthritis: a case-control and systems biology approach

    doi: 10.3389/fbinf.2026.1891543

    Figure Lengend Snippet: (a) IL2RG expression level comparison between RA patients and control serum samples; (b) IFNG expression level comparison between RA patients and control serum samples.

    Article Snippet: Further, the concentrations of IL2RG and IFNG in serum samples were quantified following the manufacturer’s protocol of human IL2RG and IFNG ELISA kits (CUSABIO catalog number: CSB-EL011651HU and CSB-E04577h-IS) and measured the absorbance at 450 nm using a Bio-Rad xMark ELISA plate reader.

    Techniques: Expressing, Comparison, Control, Blood/Plasma/Serum Samples